logo
Select company
Select metric
41.23%Cash to Assets Ratio
VS
Market
88
Sector
67
Industry
55
History
11
$ 9.42Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 388.89M$ 160.32M41.23%
3/31/2025$ 409.13M$ 180.43M44.1%
12/31/2024$ 435.02M$ 212.61M48.87%
9/30/2024$ 455.32M$ 219.2M48.14%
6/30/2024$ 347.74M$ 87.23M25.08%
3/31/2024$ 325.21M$ 103.42M31.8%
12/31/2023$ 305.05M$ 76.91M25.21%
9/30/2023$ 106.03M$ 79.6M75.07%
6/30/2023$ 139.51M$ 112.03M80.3%
3/31/2023$ 155.69M$ 125.92M80.88%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) Cash to Assets stands at 80.81%.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average Cash to Assets has been 61.23%.
  • The median Cash to Assets for CARTESIAN THERAPEUTICS INC during this period was 69.12%
  • CARTESIAN THERAPEUTICS INC reached its highest Cash to Assets over the past 5 years at 83.83%.
  • The lowest Cash to Assets recorded by CARTESIAN THERAPEUTICS INC in the same timeframe 25.08%

CARTESIAN THERAPEUTICS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
HUMA : HUMACYTE INC 63.58%NWBO : NORTHWEST BIOTHERAPEUTICS INC 14.61%MREO : MEREO BIOPHARMA GROUP PLC 89.61%INBX : INHIBRX BIOSCIENCES INC 87.95%CRDF : CARDIFF ONCOLOGY INC 14.24%BTAI : BIOXCEL THERAPEUTICS INC 72.03%CATX : PERSPECTIVE THERAPEUTICS INC 9.28%ADVM : ADVERUM BIOTECHNOLOGIES INC 46.16%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC 15.63%LSTA : LISATA THERAPEUTICS INC 66.91%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CARTESIAN THERAPEUTICS INC is calculated as follows: CashnEq [ $ 146.26M ] / Assets [ $ 181M ]
(=) Cash to Assets [ 80.81% ]

RNAC - Cash to Assets Ratio, Last 5 years

25.08%

Minimum

Jun 30, 2024

83.83%

Maximum

Dec 31, 2020

61.23%

Average

69.12%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.83% with a standard deviation of 9.6%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.89%
average9.83%
median6.44%
std9.6%